The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infectionSam Hopkins, Philippe Gallay, Jacob Lalezari et al.|Journal of Hepatology|2012Cited by 92
Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I StudyYves Horsmans, Douglas M. Heuman, Ke Hu et al.|The Journal of Clinical Pharmacology|2012Cited by 9